Try our Advanced Search for more refined results
Public Policy - October, 2004
28 articles
- Glaxo Wins First Battle In Fight Against Reimportation Of Patented Drugs
- Intellectual Property Disputes Hold Up U.S.-Australian Free Trade Agreement
- FDA Calls For Uniform Name For Biogenerics
- Canadian Branded Drug Makers Miss R&D Target
- Microsoft Lawyers Face Japanese Antitrust Panel In Dispute Over Patent Non-Assertion Clause
- India Government Unveils Details Of Patent Regime Overhaul
- Japan Bill Would Clear Way For IP Securitization
- Swiss Activists Form Coalition To Oppose Proposed Patent Law Revisions
- U.S. Constitution Bars Canadian Drug Imports, Research Paper Argues
- Germany To Oppose E.U. Software Patent Proposal
- USPTO Vows To Hire 900 New Examiners If Congress Passes Fee Bill
- IP Courts Gaining Ground Worldwide, Survey Finds
- India To Overhaul Patent Regime During Parliament's Winter Session
- U.S., Israeli Negotiators Make Progress In Talks On Drug IP Rights
- Israel Provoking Global Drug Patent Dispute, E.U. Warns
- U.S. Congress Curbs Tax Breaks For IP Donations
- Strong Job Growth In Copyright Industries, Survey Finds
- U.S. Anti-Piracy Crackdown To Be Modeled On Wars On Drugs, Terrorism
- Taiwan Sends Envoy To U.S. To Discuss Removal From IP Blacklist
- U.S., Israeli Officials To Tackle Dispute Over Drug Data Exclusivity
- Hatch Eyes Generic Biologics Bill Modeled On E.U. Approach
- Induce Act Dies In Senate Committee
- Hatch, Waxman Signal Concern About "Authorized Generics"
- USTR Moves Toward Removing Taiwan From "301" IPR Watch List
- Staunch Opponent Of Software Patents Tapped To Draft E.U. Legislation
- U.S. Unveils Initiative To Crack Down On Global Piracy
- U.S. Supreme Court Mulls Rare Review Of Patent Case
- WIPO To Convene Summit To Examine Development Proposal